Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!
Urinary metabolites were shown to help diagnose hepatocellular carcinoma. Peptide markers in both urine and bile demonstrated the ability to detect local and systemic changes in cholangiocarcinoma progression.
The data was presented at the International Liver Congress 2013, held in Amsterdam.
More Articles on Gastroenterology:
7 GI Devices Receive FDA 510(k) Clearance in April
ISMS Re-Elects Dr. John DeGuide as Trustee
La Peer Health Systems Launches Specialty GI Center
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
